BridgeBio Pharma (BBIO) Stock: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$72.44
-0.06 (-0.08%)
▼
5d:
-3.94%
30d:
-13.6%
90d:
+7.24%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 4, 2026 at $74.84 · last confirmed Sep 8, 2026
Strength: 7.5/10
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BBIO trades at premium valuation expecting 133.3% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: BBIO trades at premium valuation expecting 133.3% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $72.44, which is considered oversold relative to its 30-day fair value range of $75.99 to $83.16. From a valuation perspective, the stock is trading at a premium (Forward PE: 2634.2) compared to its historical average (207.4). At these levels, the market is pricing in 133.3% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is currently testing key support at $71.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $109.10 (+50.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is currently testing key support at $71.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $109.10 (+50.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$75.99 -
$83.16
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding BBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 50.6% below Wall St target ($109.10)
- BEARISH: Market expects 133.3% growth - appears too optimistic based on history
- NEUTRAL: Bottoming setup forming (40/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$75.99 -
$83.16
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$71.98
Resistance Level
$80.55
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2634.18
Wall Street Target
$109.10
(+50.6%)
Revenue Growth (YoY)
120.4%
Profit Margin
-97.0%
Valuation Premium vs History
+133.3% premium
PE vs Historical
2634.2 vs 207.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+133.3%
(market-implied from PE analysis)
1-Year Target
$108.66
(+50%)
2-Year Target
$162.99
(+125%)
3-Year Target
$244.49
(+238%)
3-Yr Target (if PE normalizes)
(PE: 2634→207)
PE COMPRESSION
$19.25
(-73%)
Significant PE compression expected
Share & Embed Analysis
Last updated: September 12, 2026 3:28 PM ET
Data refreshes hourly during market hours. Next update: 4:28 PM
Data refreshes hourly during market hours. Next update: 4:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2026-04-09
Gilbert Ray Cisneros, Jr.
BUY
2026-03-19
Gilbert Ray Cisneros, Jr.
BUY
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 50 HOLD |
|
JSPR
Jasper Therapeutics Inc |
STRONG BUY
11 analysts |
$7 | 62 BUY |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 64 BUY |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
